INFLAMASE OPH SOLN 0.125% DIN 00756172
Health Canada record
| Active ingredient(s) | PREDNISOLONE SODIUM PHOSPHATE 1.25 MG |
|---|---|
| Dosage form | Liquid |
| Route | Ophthalmic |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | S01BA04 PREDNISOLONE |
| Original market date | 31-Dec-1988 |
| Current status date | 09-Sep-1996 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing PREDNISOLONE SODIUM PHOSPHATE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02148498 | MINIMS PREDNISOLONE SODIUM PHOSPHATE | BAUSCH & LOMB INC | Drops | PREDNISOLONE SODIUM PHOSPHATE 0.5 % | Marketed |
| 00756164 | INFLAMASE FORTE OPH SOLN 1% | IOLAB PHARMACEUTICALS | Liquid | PREDNISOLONE SODIUM PHOSPHATE 10 MG | Cancelled Post Market |
| 02133318 | INFLAMASE FORTE OPHTHALMIC SOLUTION 1% | NOVARTIS OPHTHALMICS NOVARTIS PHARMACEUTICALS (CANADA) INC | Solution | PREDNISOLONE SODIUM PHOSPHATE 1 % | Cancelled Post Market |
| 01954237 | PMS-PREDNISOLONE SODIUM PHOSPHATE OPHTHALMIC SOLUTION FORTE | PHARMASCIENCE INC | Solution | PREDNISOLONE SODIUM PHOSPHATE 1 % | Dormant |
| 02213079 | PREDNISOLONE SODIUM PHOSPHATE 1% FORTE | RIVEX OPHTHALMICS INC. | Drops; Liquid | PREDNISOLONE SODIUM PHOSPHATE 1 % | Cancelled Post Market |
| 01924400 | R.O.-PREDPHATE TM FORTE | RICHMOND PHARMACEUTICALS INC. | Liquid; Drops | PREDNISOLONE SODIUM PHOSPHATE 1 % | Cancelled Post Market |
| 02245858 | SAB-PREDNASE | SABEX INC | Solution | PREDNISOLONE SODIUM PHOSPHATE 1 % | Cancelled Pre Market |
| 02133342 | VASOCIDIN OPHTHALMIC SOLUTION | NOVARTIS OPHTHALMICS NOVARTIS PHARMACEUTICALS (CANADA) INC | Solution | PREDNISOLONE SODIUM PHOSPHATE 2.5 MG; SULFACETAMIDE SODIUM 100 MG | Cancelled Post Market |
| 00843741 | VASOCIDIN OPHTHALMIC SOLUTION | IOLAB PHARMACEUTICALS | Liquid | PREDNISOLONE SODIUM PHOSPHATE 2.5 MG; SULFACETAMIDE SODIUM 100 MG | Cancelled Post Market |
International API supply for PREDNISOLONE SODIUM PHOSPHATE
3 valid EDQM Certificates of Suitability from 3 holders. 5 active FDA Drug Master Files.
Request a quote for INFLAMASE OPH SOLN 0.125%